Utility of reassessment after neoadjuvant therapy and difficulties in interpretation
- 22 April 2014
- journal article
- review article
- Published by Elsevier BV in Diagnostic and Interventional Imaging
- Vol. 95 (5), 495-503
- https://doi.org/10.1016/j.diii.2014.03.010
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The Use of MR Imaging in Treatment Planning for Patients with Rectal Carcinoma: Have You Checked the "DISTANCE"?Radiology, 2013
- Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meetingEuropean Radiology, 2013
- The Impact of the Introduction of Total Mesorectal Excision on Local Recurrence Rate and Survival in Rectal Cancer: Long-Term ResultsAnnals of Surgical Oncology, 2011
- Proforma-based reporting in rectal cancerCancer Imaging, 2010
- A Systematic Approach to the Interpretation of Preoperative Staging MRI for Rectal CancerAmerican Journal of Roentgenology, 2008
- Rectal Carcinoma: MRI with Histologic Correlation Before and After Chemoradiation TherapyAmerican Journal of Roentgenology, 2007
- Chemotherapy with Preoperative Radiotherapy in Rectal CancerNew England Journal of Medicine, 2006
- Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal CancerJournal of Clinical Oncology, 2006
- Improved Sphincter Preservation in Low Rectal Cancer With High-Dose Preoperative Radiotherapy: The Lyon R96-02 Randomized TrialJournal of Clinical Oncology, 2004
- Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancerBritish Journal of Cancer, 2003